Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

38
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
38
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

26
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
26
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

36
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
36
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

25
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
25
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

26
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
26
Dialysis01:15

Dialysis

703
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
703

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibronectin Peptide FNIII14 Enhances Progressive Cartilage Degeneration in Osteoarthritis by Inducing Chondrocyte Apoptosis.

Current issues in molecular biology·2026
Same author

Electron Beam Irradiation for Impact Strength Enhancement of Kevlar Fiber-Reinforced Polypropylene.

Polymers·2026
Same author

Offset Conduction Velocity Reveals Prognostic Slowing of Motor Axons in Amyotrophic Lateral Sclerosis.

Muscle & nerve·2026
Same author

Structure-Dynamics-Property Relationships in Silk Fibroin Films Probed via Solid-State NMR.

ACS omega·2026
Same author

Long-Term Outcomes of IgM-Positive Plasma Cell Tubulointerstitial Nephritis.

Kidney international reports·2026
Same author

Ribbon-like Electron-Dense Deposits in the Subepithelial Layer of Diffuse and Global Glomerular Basement Membrane in Neural Epidermal Growth Factor-like 1-Positive Membranous Nephropathy: A Case Report.

Kidney medicine·2026

Related Experiment Video

Updated: Jul 11, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K

Anti-Clogging Effect of Continuous Hemodiafiltration With Blood Recirculation.

Kazuhisa Nishimori1, Kenji Kasuno1, Naoki Takahashi1

  • 1From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|November 10, 2023
PubMed
Summary

A new continuous hemodiafiltration system with blood recirculation (CHDF-R) reduces clogging in pediatric dialysis. This innovative CHDF-R system lowers transmembrane pressure and membrane deposition compared to conventional CHDF.

More Related Videos

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.4K
Long-Term Continuous Measurement of Renal Blood Flow in Conscious Rats
05:09

Long-Term Continuous Measurement of Renal Blood Flow in Conscious Rats

Published on: February 8, 2022

2.6K

Related Experiment Videos

Last Updated: Jul 11, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

19.5K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

9.4K
Long-Term Continuous Measurement of Renal Blood Flow in Conscious Rats
05:09

Long-Term Continuous Measurement of Renal Blood Flow in Conscious Rats

Published on: February 8, 2022

2.6K

Area of Science:

  • Biomedical Engineering
  • Nephrology
  • Medical Devices

Background:

  • Pediatric dialysis necessitates low blood flow from the patient but higher flow to the hemofilter to prevent clogging.
  • Conventional continuous hemodiafiltration (CHDF) faces challenges in optimizing these flow rates simultaneously.

Purpose of the Study:

  • To introduce and evaluate a novel continuous hemodiafiltration system with blood recirculation (CHDF-R).
  • To compare the efficacy of CHDF-R against conventional CHDF in preventing hemofilter clogging.

Main Methods:

  • Development of the CHDF-R system allowing independent control of blood flow from the body and to the hemofilter.
  • Comparative analysis using bovine plasma and blood, monitoring transmembrane pressure (TMP) and hemofilter membrane surface.
  • Assessment of membrane clogging and material deposition post-dialysis.

Main Results:

  • CHDF-R demonstrated significantly lower postdialysis TMP compared to CHDF in both bovine plasma (18.1 vs 23.7) and blood (100 vs 150) experiments.
  • Significantly reduced hemofilter membrane clogging and material deposition were observed with CHDF-R.
  • CHDF-R effectively suppressed clogging substance accumulation, likely due to increased shear stress within hollow fiber membranes.

Conclusions:

  • The CHDF-R system offers a promising solution for pediatric dialysis by mitigating hemofilter clogging.
  • CHDF-R enhances hemofilter performance and longevity through improved flow dynamics and reduced deposition.
  • This technology may improve the safety and efficiency of hemodiafiltration in pediatric patients.